268 related articles for article (PubMed ID: 34391041)
1. Survey of diagnostic and treatment practices for multiple sclerosis in Russian Federation in comparison to European data.
Boykо A; Fernández O; Alifirova V; Babicheva N; Bakhtiyarova K; Volkov A; Glavinskaya N; Goncharova Z; Greshnova I; Smagina I; Lashch N; Inzhinova A; Karnaukh V; Lukashevich I; Malkova N; Poverennova I; Sivertseva S; Sinitsina L; Khoroshilova N; Sherman M; Shchur S; Yampolskaya-Gosteva I; Melnikov M; Lozovskaya I
Mult Scler Relat Disord; 2021 Oct; 55():103201. PubMed ID: 34391041
[TBL] [Abstract][Full Text] [Related]
2. Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management.
Fernández O; Delvecchio M; Edan G; Fredrikson S; Giovannoni G; Hartung HP; Havrdova E; Kappos L; Pozzilli C; Soerensen PS; Tackenberg B; Vermersch P; Comi G
Eur J Neurol; 2018 May; 25(5):739-746. PubMed ID: 29356206
[TBL] [Abstract][Full Text] [Related]
3. Survey of diagnostic and treatment practices for multiple sclerosis in Europe.
Fernández O; Delvecchio M; Edan G; Fredrikson S; Gionvannoni G; Hartung HP; Havrdova E; Kappos L; Pozzilli C; Soerensen PS; Tackenberg B; Vermersch P; Comi G
Eur J Neurol; 2017 Mar; 24(3):516-522. PubMed ID: 28139062
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of diagnosis and treatment practices of Brazilian neurologists among patients with multiple sclerosis.
Marin CE; Callegaro D; Lana-Peixoto MA; Fernández O; Gomes Neto AP; Vasconcelos CCF; d'Almeida JAC; Gonçalves MVM; Mendes MF; Parolin MKF; Nascimento O; Gama PDD; Dias-Carneiro RPC; Dias RM; Damasceno A; Becker J
Arq Neuropsiquiatr; 2021 Jul; 79(7):598-606. PubMed ID: 34468497
[TBL] [Abstract][Full Text] [Related]
5. Real-world disease-modifying therapy usage in persons with relapsing-remitting multiple sclerosis: Cross-sectional data from the Swiss Multiple Sclerosis Registry.
Bossart J; Kamm CP; Kaufmann M; Stanikić M; Puhan MA; Kesselring J; Zecca C; Gobbi C; Rapold I; Kurmann R; Ammann S; von Wyl V;
Mult Scler Relat Disord; 2022 Apr; 60():103706. PubMed ID: 35228114
[TBL] [Abstract][Full Text] [Related]
6. Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey.
Alvarez E; Nair KV; Gorritz M; Bartolome L; Maloney H; Ding Y; Golan T; Wade RL; Kumar R; Su W; Shah R; Russo P
Mult Scler Relat Disord; 2021 May; 50():102858. PubMed ID: 33799068
[TBL] [Abstract][Full Text] [Related]
7. Results from SPECTRUM: A survey of healthcare professionals to understand current diagnosis and management practices for secondary progressive multiple sclerosis in the United Kingdom.
Duddy M; Wilkinson C; Medhurst S; Rhys K
Mult Scler Relat Disord; 2021 Oct; 55():103174. PubMed ID: 34399317
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis by phenotype in Germany.
Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
[TBL] [Abstract][Full Text] [Related]
9. Disease-Modifying Therapies for Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Cost-Utility Analysis.
Zimmermann M; Brouwer E; Tice JA; Seidner M; Loos AM; Liu S; Chapman RH; Kumar V; Carlson JJ
CNS Drugs; 2018 Dec; 32(12):1145-1157. PubMed ID: 30141001
[TBL] [Abstract][Full Text] [Related]
10. [Primary-progressive multiple sclerosis in Russia: a medical-sociological study involving patients and neurologists].
Vlasov YV; Churakov MV; Kurapov MA; Gromova TN; Popova EV; Boyko OV; Spirin NN; Sivertseva SA; Belskaya GN; Malkova NA; Habirov FA; Haybullin TI; Kotov SV; Greshnova IV; Ivashinenkova EI; Bakalova MA; Yampolskaya-Gosteva IA; Boyko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8. Vyp. 2):40-46. PubMed ID: 30160667
[TBL] [Abstract][Full Text] [Related]
11. The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosis.
Taşkıran E; Terzi M; Helvacı EM; Eser MZ; Avcı B; Ömer Faruk T; Yetkin MF; Çilingir V; Bir LS; Kabay SC; Bilge N; Poyraz T; Demir CF; Dündar DK; Ocak Ö; Çam M; Mavioğlu H; Altun Y; Karaibrahimoğlu A
Mult Scler Relat Disord; 2024 Mar; 83():105391. PubMed ID: 38335838
[TBL] [Abstract][Full Text] [Related]
12. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
Knapp R; Hardtstock F; Krieger J; Wilke T; Maywald U; Chognot C; Muros-Le Rouzic E; Craveiro L
Mult Scler Relat Disord; 2022 Dec; 68():104245. PubMed ID: 36306609
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Wingerchuk DM; Carter JL
Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
[TBL] [Abstract][Full Text] [Related]
14. Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis.
Vermersch P; Martinelli V; Pfleger C; Rieckmann P; Alonso-Magdalena L; Galazka A; Dangond F; Phillips L
Clin Ther; 2019 Feb; 41(2):249-260.e18. PubMed ID: 30846120
[TBL] [Abstract][Full Text] [Related]
15. A comparison of serum inflammatory parameters in progressive forms of multiple sclerosis.
Nowak-Kiczmer M; Niedziela N; Czuba ZP; Sowa P; Wierzbicki K; Lubczyński M; Adamczyk-Sowa M
Mult Scler Relat Disord; 2023 Nov; 79():105004. PubMed ID: 37738756
[TBL] [Abstract][Full Text] [Related]
16. [Radiologically isolated syndrome as a possible preclinical stage of primary-progressive multiple sclerosis].
Popova EV; Bryukhov VV; Boyko AN; Krotenkova MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8. Vyp. 2):35-39. PubMed ID: 30160666
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice patterns in multiple sclerosis management: Mexican consensus recommendations.
Skromne-Eisenberg E; Treviño-Frenk I; Llamosa García Velázquez GL; Quiñones-Aguilar S; Rivas-Alonso V; Maza-Flores M; Macías-Islas MÁ; Llamas-López L; González-Amezquita V; León-Jiménez C; Medina-López Z; Ortiz-Maldonado JF; Santos-Diaz MA; Bertado-Cortés B; Flores-Rivera JJ; Ordóñez-Boschetti L
Mult Scler Relat Disord; 2021 Aug; 53():103053. PubMed ID: 34139461
[TBL] [Abstract][Full Text] [Related]
18. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.
Blinkenberg M; Kjellberg J; Ibsen R; Magyari M
Mult Scler Relat Disord; 2020 Nov; 46():102567. PubMed ID: 33296969
[TBL] [Abstract][Full Text] [Related]
19. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.
Kantarci OH; Lebrun C; Siva A; Keegan MB; Azevedo CJ; Inglese M; Tintoré M; Newton BD; Durand-Dubief F; Amato MP; De Stefano N; Sormani MP; Pelletier D; Okuda DT
Ann Neurol; 2016 Feb; 79(2):288-94. PubMed ID: 26599831
[TBL] [Abstract][Full Text] [Related]
20. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
